Age related macular degeneration (AMD) accounts for almost 50% of those registered as blind or partially sighted. 1-4 The development of management strategies is limited by the diverse nature of the age related changes and a lack of a clear understanding of the process of visual loss in the elderly. Effective treatment is limited to the management of sub-retinal neovascularisation (SRNV) in selected cases). Despite early expectations that laser treatment might provide significant benefit in preventing blindness 5-7 recurrent disease and progressive visual failure limit the final outcome. 8-9. Early recognition and prevention of potential disease is not as yet applicable to disease other than that related to SRNV. 

This section connects caregivers and health professionals with advice for working with older adults with vision loss. These sites offer basic tips and guidelines for interacting with people who have a visual impairment, suggestions for identifying vision loss in older people, hints for caregivers, and ideas for program design and best practices.

The present study aims to identify whether there is a gap between evidence-based recommendations for the detection of sensory loss and the current practices in Quebec Occupational Therapy educational and employment settings.

7:30am to 4:00pm at the Four Points Sheraton, 258 King St. E., Kingston, ON.  Topics for this Continuing Professional Development event include Emergency Care for the Elderly and Complex Issues in the Last Years of Life.  Register by January 13th to receive early bird pricing.

Wednesday, October 21, 2015

Aging Brain Program from the Indianapolis Discovery Network for Dementia has created a scale called the Anticholinergic Cognitive Burden (ACB). This useful list of generic and brand name medications (whether prescription or over-the-counter) are placed on a scale of one, two, or three. Based on the possible amount of anticholinergic content, one can expect more of an cognitve impairment change if used for six or more years.Drugs listed in list ONE can contain anticholinergic properties. Drugs listed in TWO and THREE have anticholinger properities that one might find interesting. Find out more about the scoring interpretations and drug names in the attached PDF file.

October 30 & 31, 2015.  This course focuses on the diagnosis and management of common geriatric syndromes and issues related to the care of older adults.  Some of this years topics include: Managing CHF, Addiction Issues, An Approach to Intimacy and Sexual Health Issues in the Elderly, Issues to Consider Around Physician Assisted Suicide, How to Approach Sleep Management with the Elderly.  For more information please see the pdf attached or visit

October 23, 2015.  Learning the Ropes for Living with MCI™ is a group intervention program for older adults with mild cognitive impairment (MCI) and their close relatives. The intervention aims to improve healthy lifestyle behaviours in all participants, functional memory skills in participants with MCI, and adaptive coping skills in close relatives. This train-the-trainer workshop includes didactic and interactive components to promote attendees’ mastery of the program content, protocol, and evaluative methods. Register Now

September 25, 2015.  This workshop trains clinicians to deliver the Memory and Aging Program®, an intervention for older adults experiencing normal age-related memory changes. The program focuses on optimizing cognitive health through lifestyle enhancement and memory training. During this workshop, participants will learn about memory changes associated with normal aging, factors affecting memory, evidence-based memory strategies, the session-by-session program protocol, and outcomes for program participants.

Fri Nov 20th 2015, 8:00am - 3:30pm Glaxo Wellcome Clinical Education Centre, Queen's University, Kingston.Do you want immediate help with your most challenging wound care patients? Register Now to improve your wound care skills by learning from regional experts through hands-on wound care training. 

This half day Continuing Professional Development event will be held at the Donald Gordon Conference Centre on Wed Nov 18th 2015, 12:00pm - 4:30pm. Attendees will develop the most appropriate treatment plans & appropriate referrals for Hepatitis C & other travel diseases; utilize updated infectious disease information to implement new prescribing practices related to drug resistant infections and implement new vaccines to improve ID prevention within their primary care practice.  Register Now